Urol. praxi. 2020;21(4):160-165 | DOI: 10.36290/uro.2020.031

Polycystic kidneys in childhood - a wide range of overlapping diseases

RNDr. Lucia Oravcová, PhD., RNDr. Katarína Skalická, PhD., MUDr. Gabriela Hrčková, prof. MUDr. Ľudmila Podracká, CSc.
Detská klinika Lekárskej fakulty Univerzity Komenského a Národného ústavu detských chorôb, Bratislava

Severe forms of early-onset polycystic kidneys in children represent a large group of diseases with overlapping clinical manifestations. A characteristic feature is enlarged kidneys with reduced function, which may be the result in Potter´s sequence in the prenatal period. However, the etiology of this manifestation is genetically very heterogeneous and can be caused by a disorder of a wide range of genes. The most common are PKHD1 mutations that lead to an autosomal recessive form of polycystic kidney (ARPKD). In almost the same number of cases the clinical manifestation of a severe form of polycystic kidney with onset in childhood is the result of PKD1 or PKD2 mutations associated with an autosomal dominant disease form (ADPKD). These mutations often arise de novo or can affect both alleles and lead to a recessive model of inheritance. Mutations in DZIP1L are a relatively new cause of the so-called ARPKD-like phenotype. Early and unambiguous diagnosis of these diseases will be confirmed by genetic testing. The current possibilities of next-generation sequencing allow simultaneous analysis of whole group of genes and represent a key role in the rapid diagnosis of these diseases. Causal gene identification is an essential tool for determining the correct diagnosis and parental counseling.

Keywords: ARPKD, PKHD1, DZIP1L, ADPKD, ciliopathies, HNF1β/TCF2, nephronophthisis.

Received: June 25, 2020; Revised: June 29, 2020; Accepted: June 29, 2020; Prepublished online: June 29, 2020; Published: January 6, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Oravcová L, Skalická K, Hrčková G, Podracká Ľ. Polycystic kidneys in childhood - a wide range of overlapping diseases. Urol. praxi. 2020;21(4):160-165. doi: 10.36290/uro.2020.031.
Download citation

References

  1. Guay-Woodford LM, Bissler JJ, Braun MC, Bockenhauer D, et al. Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference. J Pediatr. 2014; 165: 611-617. Go to original source... Go to PubMed...
  2. Kladenský J. Geneticky podmíněná onemocnění ledvin, se kterými se urolog setkává, či může setkat ve své praxi. Urol. praxi. 2019; 20(3): 123-128. Go to original source...
  3. Bergmann C, Senderek J, Windelen E. Clinical consequences of PKHD1 mutations in 164 patients with autosomal recessive polycystic kidney disease (ARPKD). Kidney Int. 2005; 829-848. Go to original source... Go to PubMed...
  4. Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 2003; 111: 1072-1080. Go to original source... Go to PubMed...
  5. Škodová E, Kratochvílová B. Bardet-Biedlův syndrom. Otorinolaryng. a Foniat. (Prague). 2012; 61(4): 261-268. Go to original source...
  6. Follit JA, Li L, Vucica Y, Pazour GJ. The cytoplasmic tail of fibrocystin contains a ciliary targeting sequence. J Cell Biol. 2010; 188: 21- 28. Go to original source... Go to PubMed...
  7. Olson RJ, Hopp K, Wells H. Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models. J Am Soc Nephrol. 2019; 30(11): 2113-2127. Go to original source... Go to PubMed...
  8. Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, et al. Mutations in ganab, encoding the glucosidase iialpha subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet. 2016; 98: 1193-1207. Go to original source... Go to PubMed...
  9. Bergmann C. Genetics of autosomal recessive polycystic kidney disease and its differential diagnoses. Front Pediatr. 2018; 5: 221. Go to original source... Go to PubMed...
  10. Xu HW, Yu SQ, Mei CL, Li MH. Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke. 2011; 42: 204-206. Go to original source... Go to PubMed...
  11. Shepherd CW, Gomez MR, Lie JT, Crowson CS. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc. 1991; 66: 792-79. Go to original source... Go to PubMed...
  12. Shillingford J, Murcia N, Larson C, Low S, et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A. 2006; 5466-5471. Go to original source... Go to PubMed...
  13. Decramer S, Parant O, Beaufils S, Clauin S, et al. Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol. 2007; 18: 923-933. Go to original source... Go to PubMed...
  14. Hiesberger T, Bai Y, Shao X, McNally BT, et al. Mutation of hepatocyte nuclear factor1beta inhibits pkhd1 gene expression and produces renal cysts in mice. J Clin Invest. 2004; 113: 814-825. Go to original source... Go to PubMed...
  15. Telega G, Cronin D, Avner ED. New approaches to the autosomal recessive polycystic kidney disease patient with dual kidneyliver complications. Pediatr Transplant .2013; 17: 328-335. Go to original source... Go to PubMed...
  16. Aamodt K, Abelev B, Abrahantes Quintana A, Adamova D, et al. Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(nn) =2.76 tev. Phys Rev Lett. 2011; 107: 032301. Go to original source... Go to PubMed...
  17. Moreno-De-Luca D, Consortium S, Mulle JG, Simons Simplex Collection Genetics C, et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet. 2010; 87: 618-630 Go to original source... Go to PubMed...
  18. Hoff S, Halbritter J, Epting D, Frank V, et al. ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Nat Genet. 2013; 45: 951- 956. Go to original source... Go to PubMed...
  19. Eckardt KU, Alper SL, Antignac C, Bleyer AJ, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management - a KDIGO consensus report. Kidney Int. 2015; 88: 676-683. Go to original source... Go to PubMed...
  20. Parisi MA. Clinical and molecular features of Joubert syndrome and related disorders. Am J Med Genet C Semin Med Genet. 2009; 151C: 326-340. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.